SCHEMBL9723325

SCHEMBL9723325

CCC(C/C=C/c1ccccc1)(C(=O)O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
TSHR P16473 1/20 0.50
PTPRC P08575 1/20 0.47
PTPN1 P18031 1/20 0.47
PAM P19021 1/20 0.46
HDAC1 Q13547 2/20 0.42
CYP2C19 P33261 1/20 0.41
NPC1 O15118 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HTT P42858 1/20 0.41
MAOB P27338 1/20 0.40
GLA P06280 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
HDAC3 O15379 2/20 0.38
S1PR4 O95977 1/20 0.38
S1PR1 P21453 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
EGFR P00533 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9723329 1.00 ALDH1A1 (0.50) ALDH1A1TSHRPTPRCPTPN1PAM
SCHEMBL504013 0.79 ALDH1A1 (0.57) ALDH1A1TSHRHDAC1CYP2C19L3MBTL1
SCHEMBL9748549 0.79 ALDH1A1 (0.80) ALDH1A1TSHRHDAC1CYP2C19HTT
Hydrogen Sulfide SCHEMBL27877649 0.77 ALDH1A1 (0.55) ALDH1A1TSHRHDAC1CYP2C19L3MBTL1
Hydrogen Sulfide SCHEMBL28874622 0.77 ALDH1A1 (0.55) ALDH1A1TSHRHDAC1CYP2C19L3MBTL1
SCHEMBL8734909 0.76 LMNA (0.51) ALDH1A1NPC1L3MBTL1MAOBGLA
SCHEMBL3997255 0.75 ALDH1A1 (0.62) ALDH1A1TSHRPTPRCPTPN1HDAC1
SCHEMBL1716940 0.75 PAM (0.53) ALDH1A1TSHRPAMHDAC1CYP2C19
SCHEMBL3997248 0.75 ALDH1A1 (0.62) ALDH1A1TSHRPTPRCPTPN1HDAC1
SCHEMBL1716939 0.75 PAM (0.53) ALDH1A1TSHRPAMHDAC1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5089639-A N-CYCLOALKYLALKYLAMINES, PROCESS FOR THEIR PREPARATION, THEIR USE AS A MEDICAMENT AND THEIR SYNTHESIS INTERMEDIATES JOUVEINAL S.A. (FR) 1992-02-18 US disclosed